Sympatholytic

Revision as of 18:21, 27 September 2011 by WikiBot (talk | contribs) (Protected "Sympatholytic": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
Jump to: navigation, search

WikiDoc Resources for Sympatholytic

Articles

Most recent articles on Sympatholytic

Most cited articles on Sympatholytic

Review articles on Sympatholytic

Articles on Sympatholytic in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Sympatholytic

Images of Sympatholytic

Photos of Sympatholytic

Podcasts & MP3s on Sympatholytic

Videos on Sympatholytic

Evidence Based Medicine

Cochrane Collaboration on Sympatholytic

Bandolier on Sympatholytic

TRIP on Sympatholytic

Clinical Trials

Ongoing Trials on Sympatholytic at Clinical Trials.gov

Trial results on Sympatholytic

Clinical Trials on Sympatholytic at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Sympatholytic

NICE Guidance on Sympatholytic

NHS PRODIGY Guidance

FDA on Sympatholytic

CDC on Sympatholytic

Books

Books on Sympatholytic

News

Sympatholytic in the news

Be alerted to news on Sympatholytic

News trends on Sympatholytic

Commentary

Blogs on Sympatholytic

Definitions

Definitions of Sympatholytic

Patient Resources / Community

Patient resources on Sympatholytic

Discussion groups on Sympatholytic

Patient Handouts on Sympatholytic

Directions to Hospitals Treating Sympatholytic

Risk calculators and risk factors for Sympatholytic

Healthcare Provider Resources

Symptoms of Sympatholytic

Causes & Risk Factors for Sympatholytic

Diagnostic studies for Sympatholytic

Treatment of Sympatholytic

Continuing Medical Education (CME)

CME Programs on Sympatholytic

International

Sympatholytic en Espanol

Sympatholytic en Francais

Business

Sympatholytic in the Marketplace

Patents on Sympatholytic

Experimental / Informatics

List of terms related to Sympatholytic

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

A sympatholytic is a medication which inhibits the functioning of the sympathetic nervous system (SNS). They are used as antihypertensives.

They mainly comprise antiadrenergic agents, but also anticholinergics in the case of the nicotinic antagonist, since nicotinic receptors relay the signals of the SNS across the ganglia.

Antiadrenergic

Antiadrenergic agents inhibit the signals of adrenaline and noradrenaline. They are mainly adrenergic antagonists, inhibiting adrenergic receptors, but there are exceptions: clonidine is an adrenergic agonist on the α2 receptor, since this receptor is located presynaptically to inhibit further release of adrenaline and noradrenaline.

Other ways of inhibiting adrenergic signaling is by catecholamine synthesis blocking, e.g. by methyltyrosine. Reserpine works by inhibiting transport into synaptic vesicles of noradrenaline by inhibiting the VMAT transporter.

In hypotension

Many antiadrenergic agents used as antihypertensives include:

External links

Cost Effectiveness of Sympatholytic

| group5 = Clinical Trials Involving Sympatholytic | list5 = Ongoing Trials on Sympatholytic at Clinical Trials.govTrial results on SympatholyticClinical Trials on Sympatholytic at Google


| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Sympatholytic | list6 = US National Guidelines Clearinghouse on SympatholyticNICE Guidance on SympatholyticNHS PRODIGY GuidanceFDA on SympatholyticCDC on Sympatholytic


| group7 = Textbook Information on Sympatholytic | list7 = Books and Textbook Information on Sympatholytic


| group8 = Pharmacology Resources on Sympatholytic | list8 = AND (Dose)}} Dosing of SympatholyticAND (drug interactions)}} Drug interactions with SympatholyticAND (side effects)}} Side effects of SympatholyticAND (Allergy)}} Allergic reactions to SympatholyticAND (overdose)}} Overdose information on SympatholyticAND (carcinogenicity)}} Carcinogenicity information on SympatholyticAND (pregnancy)}} Sympatholytic in pregnancyAND (pharmacokinetics)}} Pharmacokinetics of Sympatholytic


| group9 = Genetics, Pharmacogenomics, and Proteinomics of Sympatholytic | list9 = AND (pharmacogenomics)}} Genetics of SympatholyticAND (pharmacogenomics)}} Pharmacogenomics of SympatholyticAND (proteomics)}} Proteomics of Sympatholytic


| group10 = Newstories on Sympatholytic | list10 = Sympatholytic in the newsBe alerted to news on SympatholyticNews trends on Sympatholytic


| group11 = Commentary on Sympatholytic | list11 = Blogs on Sympatholytic

| group12 = Patient Resources on Sympatholytic | list12 = Patient resources on SympatholyticDiscussion groups on SympatholyticPatient Handouts on SympatholyticDirections to Hospitals Treating SympatholyticRisk calculators and risk factors for Sympatholytic


| group13 = Healthcare Provider Resources on Sympatholytic | list13 = Symptoms of SympatholyticCauses & Risk Factors for SympatholyticDiagnostic studies for SympatholyticTreatment of Sympatholytic

| group14 = Continuing Medical Education (CME) Programs on Sympatholytic | list14 = CME Programs on Sympatholytic

| group15 = International Resources on Sympatholytic | list15 = Sympatholytic en EspanolSympatholytic en Francais

| group16 = Business Resources on Sympatholytic | list16 = Sympatholytic in the MarketplacePatents on Sympatholytic

| group17 = Informatics Resources on Sympatholytic | list17 = List of terms related to Sympatholytic


}}



Linked-in.jpg